These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 37461720)
21. Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity. Nguyen KQ; Tsou WI; Calarese DA; Kimani SG; Singh S; Hsieh S; Liu Y; Lu B; Wu Y; Garforth SJ; Almo SC; Kotenko SV; Birge RB J Biol Chem; 2014 Sep; 289(37):25737-49. PubMed ID: 25074939 [TBL] [Abstract][Full Text] [Related]
22. Skull bone marrow-derived immune cells infiltrate the injured cerebral cortex and exhibit anti-inflammatory properties. Soliman E; Gudenschwager Basso EK; Ju J; Willison A; Theus MH Brain Behav Immun; 2025 Jan; 123():244-253. PubMed ID: 39293691 [TBL] [Abstract][Full Text] [Related]
23. Monocyte proinflammatory phenotypic control by ephrin type A receptor 4 mediates neural tissue damage. Kowalski EA; Soliman E; Kelly C; Basso EKG; Leonard J; Pridham KJ; Ju J; Cash A; Hazy A; de Jager C; Kaloss AM; Ding H; Hernandez RD; Coleman G; Wang X; Olsen ML; Pickrell AM; Theus MH JCI Insight; 2022 Aug; 7(15):. PubMed ID: 35737458 [TBL] [Abstract][Full Text] [Related]
24. Elevated expression of macrophage MERTK exhibits profibrotic effects and results in defective regulation of efferocytosis function in pulmonary fibrosis. She Y; Xu X; Yu Q; Yang X; He J; Tang XX Respir Res; 2023 Apr; 24(1):118. PubMed ID: 37120511 [TBL] [Abstract][Full Text] [Related]
25. STAT6 induces expression of Gas6 in macrophages to clear apoptotic neutrophils and resolve inflammation. Nepal S; Tiruppathi C; Tsukasaki Y; Farahany J; Mittal M; Rehman J; Prockop DJ; Malik AB Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16513-16518. PubMed ID: 31363052 [TBL] [Abstract][Full Text] [Related]
26. Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers. Grabiec AM; Goenka A; Fife ME; Fujimori T; Hussell T Eur J Immunol; 2018 May; 48(5):855-860. PubMed ID: 29400409 [TBL] [Abstract][Full Text] [Related]
27. Skull bone marrow-derived immune cells infiltrate the damaged cortex and exhibit anti-inflammatory properties. Soliman E; Basso EKG; Ju J; Willison A; Theus MH bioRxiv; 2024 Jun; ():. PubMed ID: 38948756 [TBL] [Abstract][Full Text] [Related]
28. Resolvin D1 promotes efferocytosis in aging by limiting senescent cell-induced MerTK cleavage. Rymut N; Heinz J; Sadhu S; Hosseini Z; Riley CO; Marinello M; Maloney J; MacNamara KC; Spite M; Fredman G FASEB J; 2020 Jan; 34(1):597-609. PubMed ID: 31914705 [TBL] [Abstract][Full Text] [Related]
29. Mechanism of Efferocytosis in Determining Ischaemic Stroke Resolution-Diving into Microglia/Macrophage Functions and Therapeutic Modality. Xie XD; Dong SS; Liu RJ; Shi LL; Zhu T Mol Neurobiol; 2024 Oct; 61(10):7583-7602. PubMed ID: 38409642 [TBL] [Abstract][Full Text] [Related]
30. Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT Zhang Y; Wang Y; Zhou D; Zhang LS; Deng FX; Shu S; Wang LJ; Wu Y; Guo N; Zhou J; Yuan ZY Am J Physiol Cell Physiol; 2019 Oct; 317(4):C776-C787. PubMed ID: 31390228 [TBL] [Abstract][Full Text] [Related]
31. Targeted delivery of MerTK protein via cell membrane engineered nanoparticle enhances efferocytosis and attenuates atherosclerosis in diabetic ApoE Qiu S; Liu J; Chen J; Li Y; Bu T; Li Z; Zhang L; Sun W; Zhou T; Hu W; Yang G; Yuan L; Duan Y; Xing C J Nanobiotechnology; 2024 Apr; 22(1):178. PubMed ID: 38614985 [TBL] [Abstract][Full Text] [Related]
32. MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression. Lin J; Xu A; Jin J; Zhang M; Lou J; Qian C; Zhu J; Wang Y; Yang Z; Li X; Yu W; Liu B; Tao H Oncoimmunology; 2022; 11(1):2024941. PubMed ID: 35036076 [TBL] [Abstract][Full Text] [Related]
33. Immunoproteasome subunit β5i regulates diet-induced atherosclerosis through altering MERTK-mediated efferocytosis in Apoe knockout mice. Liao J; Xie Y; Lin Q; Yang X; An X; Xia Y; Du J; Wang F; Li HH J Pathol; 2020 Mar; 250(3):275-287. PubMed ID: 31758542 [TBL] [Abstract][Full Text] [Related]
34. MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity. Cai B; Kasikara C; Doran AC; Ramakrishnan R; Birge RB; Tabas I Sci Signal; 2018 Sep; 11(549):. PubMed ID: 30254055 [TBL] [Abstract][Full Text] [Related]
35. Macrophages reprogram after ischemic stroke and promote efferocytosis and inflammation resolution in the mouse brain. Zhang W; Zhao J; Wang R; Jiang M; Ye Q; Smith AD; Chen J; Shi Y CNS Neurosci Ther; 2019 Dec; 25(12):1329-1342. PubMed ID: 31697040 [TBL] [Abstract][Full Text] [Related]
36. Disturbed flow impairs MerTK-mediated efferocytosis in aortic endothelial cells during atherosclerosis. Wu J; Liu S; Banerjee O; Shi H; Xue B; Ding Z Theranostics; 2024; 14(6):2427-2441. PubMed ID: 38646649 [No Abstract] [Full Text] [Related]
37. The PPAR-γ antagonist GW9662 elicits differentiation of M2c-like cells and upregulation of the MerTK/Gas6 axis: a key role for PPAR-γ in human macrophage polarization. Zizzo G; Cohen PL J Inflamm (Lond); 2015; 12():36. PubMed ID: 25972766 [TBL] [Abstract][Full Text] [Related]
38. ODC (Ornithine Decarboxylase)-Dependent Putrescine Synthesis Maintains MerTK (MER Tyrosine-Protein Kinase) Expression to Drive Resolution. Yurdagul A; Kong N; Gerlach BD; Wang X; Ampomah P; Kuriakose G; Tao W; Shi J; Tabas I Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):e144-e159. PubMed ID: 33406854 [TBL] [Abstract][Full Text] [Related]
39. The Tolerogenic Influence of Dexamethasone on Dendritic Cells Is Accompanied by the Induction of Efferocytosis, Promoted by MERTK. Li V; Binder MD; Kilpatrick TJ Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958886 [TBL] [Abstract][Full Text] [Related]
40. MerTK-dependent efferocytosis by monocytic-MDSCs mediates resolution of post-lung transplant injury. Leroy V; Manual Kollareth DJ; Tu Z; Valisno JAC; Woolet-Stockton M; Saha B; Emtiazjoo AM; Rackauskas M; Moldawer LL; Efron PA; Cai G; Atkinson C; Upchurch GR; Sharma AK bioRxiv; 2024 Jan; ():. PubMed ID: 38328174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]